
Charles River Laboratories ownership: holders and insider trading
$335.52−0.72%Close 16 Nov 2026 · Market value $16.05B
As filed, its directors and officers own 1.3% of the shares (proxy statement, 16 Mar 2026); 569 institutional managers reported holding 98.7% at 30 Jun 2026. Over the last twelve months, insiders bought $7.34K and sold $52.07M of shares on the open market, $49.09M of it under 10b5-1 plans set in advance.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| FMR LLC | Holder | 5.9M | 12.4% | Schedule 13G | 30 Sep 2026 |
|---|
| The Vanguard Group, Inc. | Holder | 5.8M | 12.12%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 4.2M | 8.86%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock, Inc. | Holder | 3.8M | 7.93%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 3.6M | 7.38% | Schedule 13G | 31 Mar 2026 |
|---|
| T. Rowe Price | Institution | 3.0M | 6.3% | Schedule 13G | 30 Sep 2026 |
|---|
| Harris Associates L P | Institution | 2.2M | 4.68%* | Form 13F | 30 Jun 2026 |
|---|
| Allspring Global Investments Holdings, LLC | Institution | 1.9M | 3.98%* | Form 13F | 30 Jun 2026 |
|---|
| State Street | Institution | 1.9M | 3.89%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco, Ltd. | Holder | 1.9M | 3.9% | Schedule 13G | 30 Sep 2026 |
|---|
| Dimensional Fund Advisors | Institution | 1.6M | 3.44%* | Form 13F | 30 Jun 2026 |
|---|
| Ariel Investments, LLC | Institution | 1.5M | 3.15%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 1.3M | 2.73%* | Form 13F | 30 Jun 2026 |
|---|
| Wellington Management | Institution | 1.3M | 2.69%* | Form 13F | 30 Jun 2026 |
|---|
| Citadel | Institution | 1.2M | 2.49%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 1.2M | 2.45%* | Form 13F | 30 Jun 2026 |
|---|
| Earnest Partners LLC | Institution | 1.1M | 2.34%* | Form 13F | 30 Jun 2026 |
|---|
| Ameriprise | Institution | 881K | 1.84%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 872K | 1.82%* | Form 13F | 30 Jun 2026 |
|---|
| Neuberger Berman Group LLC | Institution | 863K | 1.80%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Knell Michael Gunnar · SVP, Finance and CAO | 6 Nov 2026 | Shares withheld for tax | −649 | $313.02 | $203.1K |
|---|
| FOSTER JAMES C · Director | 22 Oct 2026 | Option exercise | +24.0K | $244.41 | $5.88M |
|---|
| FOSTER JAMES C · Director | 22 Oct 2026 | Open-market sale (10b5-1 plan) | −24.0K | $350.00 | $8.41M |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 21 Oct 2026 | Option exercise | +2.2K | $244.41 | $526.9K |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 21 Oct 2026 | Open-market sale (10b5-1 plan) | −2.2K | $344.41 | $742.5K |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 5 Oct 2026 | Option exercise | +981 | $208.44 | $204.5K |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 5 Oct 2026 | Open-market sale (10b5-1 plan) | −981 | $308.44 | $302.6K |
|---|
| Coleman Glenn · EVP & Chief Financial Officer | 30 Sep 2026 | Open-market purchase | +10 | $297.43 | $2.97K |
|---|
| FOSTER JAMES C · Director | 25 Aug 2026 | Option exercise | +12.4K | $208.44 | $2.59M |
|---|
| FOSTER JAMES C · Director | 25 Aug 2026 | Option exercise | +21.1K | $194.12 | $4.10M |
|---|
| FOSTER JAMES C · Director | 25 Aug 2026 | Open-market sale (10b5-1 plan) | −33.6K | $300.00 | $10.07M |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 19 Aug 2026 | Open-market sale (10b5-1 plan) | −2.0K | $294.12 | $599.7K |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 19 Aug 2026 | Option exercise | +2.0K | $194.12 | $395.8K |
|---|
| Andrews Nancy C · Director | 18 Aug 2026 | Option exercise | +573 | $164.30 | $94.14K |
|---|
| Andrews Nancy C · Director | 18 Aug 2026 | Open-market sale | −573 | $285.24 | $163.4K |
|---|
| Girshick Birgit · Chief Executive Officer · Director | 11 Aug 2026 | Open-market sale (10b5-1 plan) | −6.5K | $279.90 | $1.82M |
|---|
| Girshick Birgit · Chief Executive Officer · Director | 11 Aug 2026 | Option exercise | +6.5K | $179.66 | $1.17M |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 11 Aug 2026 | Open-market sale (10b5-1 plan) | −3.7K | $279.66 | $1.04M |
|---|
| Parisotto Shannon M · CEVP, Disc & Safety Assessment | 11 Aug 2026 | Option exercise | +3.7K | $179.66 | $667.3K |
|---|
| FOSTER JAMES C · Director | 10 Aug 2026 | Option exercise | +28.7K | $179.66 | $5.16M |
|---|
| FOSTER JAMES C · Director | 10 Aug 2026 | Open-market sale (10b5-1 plan) | −28.7K | $275.00 | $7.90M |
|---|
| Knell Michael Gunnar · SVP, Finance and CAO | 6 Aug 2026 | Open-market sale | −1.3K | $259.07 | $330.1K |
|---|
| Knell Michael Gunnar · SVP, Finance and CAO | 6 Aug 2026 | Open-market sale | −901 | $260.63 | $234.8K |
|---|
| Knell Michael Gunnar · SVP, Finance and CAO | 6 Aug 2026 | Open-market sale | −810 | $261.45 | $211.8K |
|---|
| Knell Michael Gunnar · SVP, Finance and CAO | 6 Aug 2026 | Open-market sale | −213 | $262.37 | $55.88K |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
CRL in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.